南美和中美洲肌肉减少症治疗市场预测至 2030 年 - 区域分析 - 按治疗类型（维生素 D 和钙补充剂、蛋白质补充剂、维生素 B12 补充剂等）和分销渠道（药店、零售渠道、在线渠道等）
临床试验阶段的产品推动南美和中美肌肉减少症治疗市场的发展
肌肉减少症治疗市场中的一些主要参与者越来越关注治疗肌肉减少症的药物开发。新型肌肉减少症治疗方法目前正在开发和临床试验中测试。下面列出了其中一些产品：
临床开发中的肌肉减少症药物
公司名称
干预措施
病症
临床试验阶段
雅培营养
含 AN777 的医疗食品
口服营养配方
营养不良
肌肉减少症
PHASE3
纽迪西亚研究
膳食补充剂：Bolus ONS A
膳食补充剂：Bolus ONS B
膳食补充剂：Bolus ONS C
膳食补充剂：Bolus ONS D
肌肉减少症
PHASE1
诺华制药
药物：Bimagrumab
肌肉减少症
第 2 阶段
麦克马斯特大学
行为：减少步骤
肌肉减少症
第 1 阶段
代谢技术公司
膳食补充剂：安慰剂
药物：HMB 加维生素 D
行为：非运动
行为：运动
肌肉减少症
第 1 阶段
默克夏普和多姆有限责任公司
药物：对照品 MK-077
药物：对照品安慰剂
肌肉减少症
第 2 阶段
Immunotec 公司
膳食补充剂：Immunocal
膳食补充剂：酪蛋白
衰老和肌肉减少症
第 2 阶段
杨丽君
组合产品：3个月强化干预
肌肉减少症
PHASE4
Regeneron Pharmaceuticals
药物：REGN1033 (SAR391786)
药物：安慰剂
肌肉减少症
PHASE2
来源：公司网站和 Insight Partners 分析
因此，处于不同临床开发阶段的药物管道不断扩大，为肌肉减少症治疗市场的增长提供了重大机遇。
南美和中美肌肉减少症治疗市场概览
南美和中美的肌肉减少症治疗市场分为巴西、阿根廷和南美和中美其他地区。老年人口的增加和维生素缺乏症发病率的飙升推动了南美和中美肌肉减少症治疗市场的发展。
2018 年，国家卫生监督局 (ANVISA) 出台了新的膳食补充剂法规，使新品牌更容易进入巴西。此外，它还帮助现有品牌在该国蓬勃发展和创新。根据美国国家医学图书馆发表的一项研究，巴西老年人口正在迅速增长，导致与老年相关的慢性病患病率上升。2020 年，巴西老年人口中肌少症的总体患病率约为 20.0%。根据美国国立卫生研究院发表的一篇文章，2022 年，巴西老年女性中肌少症的患病率为 42.0%。
南美和中美肌肉减少症治疗市场收入及预测至 2030 年（百万美元）
南美和中美肌肉减少症治疗市场细分
南美和中美肌肉减少症治疗市场分为治疗类型、分销渠道和国家。
根据治疗类型，南美和中美肌肉减少症治疗市场细分为维生素 D 和钙补充剂、蛋白质补充剂、维生素 B12 补充剂等。维生素 D 和钙补充剂细分市场在 2022 年占据了南美和中美肌肉减少症治疗市场的最大份额。
在分销渠道方面，南美和中美肌肉减少症治疗市场细分为药店、零售渠道、在线渠道和其他。 2022 年，药房部门占据了南美和中美肌肉减少症治疗市场的最大份额。
按国家/地区划分，南美和中美肌肉减少症治疗市场分为巴西、阿根廷和南美和中美洲其他地区。2022 年，巴西占据了南美和中美肌肉减少症治疗市场的主导地位。
雅培实验室、拜耳公司、雀巢健康科学公司、诺华公司、辉瑞公司、赛诺菲公司、安利公司和葛兰素史克公司是南美和中美肌肉减少症治疗市场的一些领先公司。
TABLE OF CONTENTS
1. Introduction
1.1 The Insight Partners Research Report Guidance
1.2 Market Segmentation
2. Executive Summary
2.1 Key Insights
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. South & Central America Sarcopenia Treatment Market - Key Industry Dynamics
4.1 South & Central America Sarcopenia Treatment Market - Key Industry Dynamics
4.2 Market Drivers
4.2.1 Upsurge in Geriatric Population
4.2.2 Rise in Malnutrition and Vitamin Deficiency Among Adults
4.3 Key Market Restraints:
4.3.1 Unavailability of Direct Interventions
4.4 Key Market Opportunities:
4.4.1 Products in Clinical Trial Phases
4.5 Future Trends:
4.5.1 Rising Awareness About Sarcopenia
4.6 Impact of Drivers and Restraints:
5. Sarcopenia Treatment Market - South & Central America Market Analysis
5.1 South & Central America Sarcopenia Treatment Market Revenue (US$ Million), 2020- 2030
5.2 South & Central America Sarcopenia Treatment Market Forecast and Analysis
6. South & Central America Sarcopenia Treatment Market Analysis - By Treatment Type
6.1 Vitamin D and Calcium Supplement
6.1.1 Overview
6.1.2 Vitamin D and Calcium Supplement: South & Central America Sarcopenia Treatment Market, Revenue and Forecast to 2030 (US$ Million)
6.2 Protein Supplement
6.2.1 Overview
6.2.2 Protein Supplement: South & Central America Sarcopenia Treatment Market, Revenue and Forecast to 2030 (US$ Million)
6.3 Vitamin B12 Supplement
6.3.1 Overview
6.3.2 Vitamin B12 Supplement: South & Central America Sarcopenia Treatment Market, Revenue and Forecast to 2030 (US$ Million)
6.4 Others
6.4.1 Overview
6.4.2 Others: South & Central America Sarcopenia Treatment Market, Revenue and Forecast to 2030 (US$ Million)
7. South & Central America Sarcopenia Treatment Market Analysis - By Distribution Channel
7.1 Pharmacies
7.1.1 Overview
7.1.2 Pharmacies: South & Central America Sarcopenia Treatment Market Revenue and Forecast to 2030 (US$ Million)
7.2 Retail Channels
7.2.1 Overview
7.2.2 Retail Channels: South & Central America Sarcopenia Treatment Market, Revenue and Forecast to 2030 (US$ Million)
7.3 Online Channels
7.3.1 Overview
7.3.2 Online Channels : South & Central America Sarcopenia Treatment Market, Revenue and Forecast to 2030 (US$ Million)
7.4 Others
7.4.1 Overview
7.4.2 Others: South & Central America Sarcopenia Treatment Market Revenue and Forecast to 2030 (US$ Million)
8. South & Central America Sarcopenia Treatment Market - Country Analysis
8.1 South & Central America
8.1.1 South & Central America Sarcopenia Treatment Market Revenue and Forecast and Analysis - By Country
8.1.1.1 South & Central America Sarcopenia Treatment Market Revenue and Forecast and Analysis - By Country
8.1.1.2 Brazil Sarcopenia Treatment Market Revenue and Forecast to 2030 (US$ Mn)
8.1.1.2.1 Brazil Sarcopenia Treatment Market Breakdown by Treatment Type
8.1.1.2.2 Brazil Sarcopenia Treatment Market Breakdown by Distribution Channel
8.1.1.3 Argentina Sarcopenia Treatment Market Revenue and Forecast to 2030 (US$ Mn)
8.1.1.3.1 Argentina Sarcopenia Treatment Market Breakdown by Treatment Type
8.1.1.3.2 Argentina Sarcopenia Treatment Market Breakdown by Distribution Channel
8.1.1.4 Rest of South & Central America Sarcopenia Treatment Market Revenue and Forecast to 2030 (US$ Mn)
8.1.1.4.1 Rest of South & Central America Sarcopenia Treatment Market Breakdown by Treatment Type
8.1.1.4.2 Rest of South & Central America Sarcopenia Treatment Market Breakdown by Distribution Channel
9. Sarcopenia Treatment Market-Industry Landscape
9.1 Overview
9.2 Growth Strategies in the Sarcopenia Treatment Market
9.3 Inorganic Growth Strategies
9.3.1 Overview
9.4 Organic Growth Strategies
9.4.1 Overview
10. Company Profiles
10.1 Abbott Laboratories
10.1.1 Key Facts
10.1.2 Business Description
10.1.3 Products and Services
10.1.4 Financial Overview
10.1.5 SWOT Analysis
10.1.6 Key Developments
10.2 Bayer AG
10.2.1 Key Facts
10.2.2 Business Description
10.2.3 Products and Services
10.2.4 Financial Overview
10.2.5 SWOT Analysis
10.2.6 Key Developments
10.3 Nestle Health Science SA
10.3.1 Key Facts
10.3.2 Business Description
10.3.3 Products and Services
10.3.4 Financial Overview
10.3.5 SWOT Analysis
10.3.6 Key Developments
10.4 Novartis AG
10.4.1 Key Facts
10.4.2 Business Description
10.4.3 Products and Services
10.4.4 Financial Overview
10.4.5 SWOT Analysis
10.4.6 Key Developments
10.5 Pfizer Inc
10.5.1 Key Facts
10.5.2 Business Description
10.5.3 Products and Services
10.5.4 Financial Overview
10.5.5 SWOT Analysis
10.5.6 Key Developments
10.6 Sanofi SA
10.6.1 Key Facts
10.6.2 Business Description
10.6.3 Products and Services
10.6.4 Financial Overview
10.6.5 SWOT Analysis
10.6.6 Key Developments
10.7 Amway Corp
10.7.1 Key Facts
10.7.2 Business Description
10.7.3 Products and Services
10.7.4 Financial Overview
10.7.5 SWOT Analysis
10.7.6 Key Developments
10.8 GSK Plc
10.8.1 Key Facts
10.8.2 Business Description
10.8.3 Products and Services
10.8.4 Financial Overview
10.8.5 SWOT Analysis
10.8.6 Key Developments
11. Appendix
11.1 About The Insight Partners
11.2 Glossary of Terms
List of Tables
Table 1. South & Central America Sarcopenia Treatment Market Segmentation
Table 2. Sarcopenia Drug Under Clinical Development
Table 3. South & Central America Sarcopenia Treatment Market - Revenue and Forecast to 2030(US$ Million)
Table 4. South & Central America Sarcopenia Treatment Market - Revenue and Forecast to 2030(US$ Million) - By Treatment Type
Table 5. South & Central America Sarcopenia Treatment Market - Revenue and Forecast to 2030(US$ Million) - By Distribution Channel
Table 6. South & Central America Sarcopenia Treatment Market - Revenue and Forecast to 2030(US$ Mn) - By Country
Table 7. Brazil Sarcopenia Treatment Market - Revenue and Forecast to 2030(US$ Mn) - By Treatment Type
Table 8. Brazil Sarcopenia Treatment Market - Revenue and Forecast to 2030(US$ Mn) - By Distribution Channel
Table 9. Argentina Sarcopenia Treatment Market - Revenue and Forecast to 2030(US$ Mn) - By Treatment Type
Table 10. Argentina Sarcopenia Treatment Market - Revenue and Forecast to 2030(US$ Mn) - By Distribution Channel
Table 11. Rest of South & Central America Sarcopenia Treatment Market - Revenue and Forecast to 2030(US$ Mn) - By Treatment Type
Table 12. Rest of South & Central America Sarcopenia Treatment Market - Revenue and Forecast to 2030(US$ Mn) - By Distribution Channel
Table 13. Recent Inorganic Growth Strategies in the Sarcopenia Treatment Market
Table 14. Recent Organic Growth Strategies in the Sarcopenia Treatment Market
Table 15. Glossary of Terms, Sarcopenia Treatment Market
List of Figures
Figure 1. South & Central America Sarcopenia Treatment Market Segmentation, By Country
Figure 2. Impact Analysis of Drivers and Restraints
Figure 3. South & Central America Sarcopenia Treatment Market Revenue (US$ Million), 2020 - 2030
Figure 4. South & Central America Sarcopenia Treatment Market Share (%) - By Treatment Type, 2022 and 2030
Figure 5. Vitamin D and Calcium Supplement: South & Central America Sarcopenia Treatment Market Revenue and Forecasts to 2030 (US$ Million)
Figure 6. Protein Supplement: South & Central America Sarcopenia Treatment Market Revenue and Forecasts to 2030 (US$ Million)
Figure 7. Vitamin B12 Supplement: South & Central America Sarcopenia Treatment Market Revenue and Forecasts to 2030 (US$ Million)
Figure 8. Others: South & Central America Sarcopenia Treatment Market Revenue and Forecasts to 2030 (US$ Million)
Figure 9. South & Central America Sarcopenia Treatment Market Share (%) - By Distribution Channel, 2022 and 2030
Figure 10. Pharmacies: South & Central America Sarcopenia Treatment Market Revenue and Forecasts to 2030 (US$ Million)
Figure 11. Retail Channels: South & Central America Sarcopenia Treatment Market Revenue and Forecasts to 2030 (US$ Million)
Figure 12. Online Channels : South & Central America Sarcopenia Treatment Market Revenue and Forecasts to 2030 (US$ Million)
Figure 13. Others: South & Central America Sarcopenia Treatment Market Revenue and Forecasts to 2030 (US$ Million)
Figure 14. South & Central America Sarcopenia Treatment Market Revenue, by Key Countries, (2022) (US$ Mn)
Figure 15. South & Central America Sarcopenia Treatment Market Breakdown by Key Countries, 2022 and 2030 (%)
Figure 16. Brazil Sarcopenia Treatment Market - Revenue and Forecast to 2030(US$ Mn)
Figure 17. Argentina Sarcopenia Treatment Market - Revenue and Forecast to 2030(US$ Mn)
Figure 18. Rest of South & Central America Sarcopenia Treatment Market - Revenue and Forecast to 2030(US$ Mn)
Figure 19. Growth Strategies in the Sarcopenia Treatment Market
1. Abbott Laboratories
2. Bayer AG
3. Nestle Health Science SA
4. Novartis AG
5. Pfizer Inc
6. Sanofi SA
7. Amway Corp
8. GSK Plc
- Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the South & Central America sarcopenia treatment market.
- Highlights key business priorities in order to assist companies to realign their business strategies.
- The key findings and recommendations highlight crucial progressive industry trends in the South & Central America sarcopenia treatment market, thereby allowing players across the value chain to develop effective long-term strategies.
- Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
- Scrutinize in-depth South & Central America market trends and outlook coupled with the factors driving the South & Central America sarcopenia treatment market, as well as those hindering it.
- Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to client products, segmentation, pricing, and distribution.